276
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 219-236 | Received 27 Oct 2023, Accepted 23 Feb 2024, Published online: 18 Mar 2024